I'm assuming a placement twice the size at double the price, so $24m at 36c. This would add 66.6m shares giving a total of 516m shares. That would provide enough funds until end of 2019. I would expect about a $300m market cap during this period, so around 60 cents per share average.
By the time 2020 rolls around I would expect ASR to be significantly higher, and thus a catalyst for another round of funding at a higher price. Perhaps around the $1 mark for another 100m shares, giving a total of around 600m shares, so $600m MC.
$600m does seem high but by then it would have risen, $12m IPO + $12m just now, $36m + $100m for a total of $160m raised. Buy this stage I would assume it would be in a similar situation as ACX, which got taken over by Oracle for $1.6b. So this would equate to about $2.66 per share, or about a 14 bagger on the recent placement at 18cents.
- Forums
- ASX - By Stock
- Ann: LiveTiles, Microsoft Join Forces in Fast-Growing AI Industry
I'm assuming a placement twice the size at double the price, so...
Featured News
Add LVT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online